MedPath

赤峰维康生化制药有限公司

Ownership
-
Established
1998-07-01
Employees
-
Market Cap
-
Website
www.chinawkzy.com

Clinical Trials

0

Active:0
Completed:0

Trial Phases

0 Phases

Drug Approvals

86

NMPA:86

Drug Approvals

Compound Aspirin Tablets

Product Name
复方乙酰水杨酸片
Approval Number
国药准字H15020844
Approval Date
Apr 11, 2025
NMPA

Metformin Hydrochloride Tablets

Product Name
盐酸二甲双胍片
Approval Number
国药准字H20253297
Approval Date
Jan 24, 2025
NMPA

Enalapril Maleate and Hydrochlorothiazide Dispersible Tablets

Product Name
依那普利氢氯噻嗪分散片
Approval Number
国药准字H20080070
Approval Date
Mar 5, 2023
NMPA

Lomefloxacin Hydrochloride Dispersible Tablets

Product Name
百夜星
Approval Number
国药准字H20080503
Approval Date
Apr 15, 2020
NMPA

Compound Aminopyrine Phenacetin Tablets

Product Name
去痛片
Approval Number
国药准字H15020884
Approval Date
Apr 15, 2020
NMPA

Sodium Houttuyfonate Tablets

Product Name
鱼腥草素钠片
Approval Number
国药准字H15020888
Approval Date
Apr 15, 2020
NMPA

Raceanisodamine Tablets

Product Name
消旋山莨菪碱片
Approval Number
国药准字H15020855
Approval Date
Apr 15, 2020
NMPA

Nifedipine Tablets

Product Name
硝苯地平片
Approval Number
国药准字H15020854
Approval Date
Apr 15, 2020
NMPA

Ranitidine Hydrochloride Capsules

Product Name
盐酸雷尼替丁胶囊
Approval Number
国药准字H15020856
Approval Date
Apr 15, 2020
NMPA

Acetylspiramycin Tablets

Product Name
乙酰螺旋霉素片
Approval Number
国药准字H15020869
Approval Date
Apr 15, 2020
NMPA
  • Prev
  • 1
  • 2
  • 3
  • 4
  • 5
  • 9
  • Next

Clinical Trials

No trials found

News

No news found

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.